A new study has shown that having the seasonal flu vaccine could reduce the risk of suffering a stroke by almost a quarter.
Researchers from the University of Lincoln and the University of Nottingham discovered that patients who had been vaccinated against flu were 24% less likely to suffer a stroke in the same flu season.
The research was headed by Professor Niro Siriwardena, who is Professor of Primary and Pre-hospital Healthcare in the School of Health and Social Care at the University of Lincoln and also a GP and Research Lead with Lincolnshire Community Health Services NHS Trust. He said: "The causes of stroke are not fully understood. Classical risk factors like age, smoking and high blood pressure can account for just over half of all cases.
"We know that cardiovascular diseases tend to hit during winter and that the risks may be heightened by respiratory infections such as flu.
"Our study showed a highly significant association between flu vaccination and reduced risk of stroke within the same flu season. The results were consistent with our previous research into heart attack risk."
Dr Zahid Asghar, statistician on the project, supported by Dr Carol Coupland (University of Nottingham) analysed records of more than 47,000 patients who had suffered a stroke or TIA (transient ischaemic attack) between 2001 and 2009. Data were drawn from the UK's national General Practice Research Database. Alongside flu vaccine take-up, they also looked at take-up of pneumococcal vaccination, which protects against infections such as pneumonia.
They found flu vaccination was associated with a 24% reduction in risk of stroke. The reduction was strongest if the vaccination was given early in the flu season. There was no statistically significant change in risk of TIA with flu vaccination. Pneumococcal vaccination did not appear to reduce risks of either stroke or TIA.
The study, called IPVASTIA, used a matched case-control design. Actual cases of stroke were compared against 'control' patients, adjusted for other factors that might explain the differences in risk associated with flu vaccination such as age, existing diseases and treatment history. This type of analysis is widely used in health research to identify risk factors in large samples, although it cannot prove direct cause-and-effect relationships.
Professor Siriwardena added: "Further experimental studies would be needed to better understand the relationship between flu vaccination and stroke risk. However, these findings reinforce the value of the UK's national flu vaccination programme with reduced risk of stroke appearing to be an added health benefit."
In the UK the seasonal flu vaccination is recommended for everyone over 65 years of age and other at-risk groups, such as those with disabilities or chronic illnesses. Take-up of the vaccine across England is lower than national targets at 74% for over-65s in 2011/12 and around 52% for under-65s in at-risk groups.
The study by Professor Siriwardena and his co-researchers features on a new website, www.FocusOnStroke.nihr.ac.uk, which has been launched by the National Institute for Health Research and aims to give the public a greater insight into the subject of stroke.
The study is reported in the scientific journal Vaccine.